Lead Product(s) : Undisclosed
Therapeutic Area : Musculoskeletal
Study Phase : Discovery Platform
Sponsor : SOLVE FSHD
Deal Size : Undisclosed
Deal Type : Collaboration
SOLVE FSHD, Transcripta Collaborate on Drug Discovery for FSHD
Details : The collaboration will focus on leveraging Transcripta Bio’s advanced drug screening platform to identify and develop promising therapeutic candidates for FSHD.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
March 25, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Musculoskeletal
Highest Development Status : Discovery Platform
Sponsor : SOLVE FSHD
Deal Size : Undisclosed
Deal Type : Collaboration